Use of olanzapine in hereditary coproporphyria

Psychosomatics. 1999 Sep-Oct;40(5):444-5. doi: 10.1016/S0033-3182(99)71211-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines
  • Disorders of Excessive Somnolence / chemically induced
  • Humans
  • Male
  • Olanzapine
  • Pirenzepine / adverse effects
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / therapeutic use
  • Porphobilinogen / urine*
  • Porphyrias, Hepatic / complications*
  • Porphyrias, Hepatic / diagnosis*
  • Porphyrias, Hepatic / urine
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / etiology
  • Psychotic Disorders / urine
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Pirenzepine
  • Porphobilinogen
  • Olanzapine